WHITE PLAINS, N.Y., Oct. 10, 2012 /PRNewswire/ -- Parthenon Associates, LLC ("Parthenon" www.parthenonassociates.com), a Financial Consulting firm that provides consulting and strategic advisory services to Life Sciences, Biotechnology, and Development-Stage Technology companies, will webcast live an interview with Philip Cohen, the main author of "TARGETED PAYLOAD CANCER THERAPEUTICS: THE NEXT GENERATION EMERGES", an industry report on Targeted Payload Cancer Therapeutics (TPCTs). The report examines the promise of TPCTs, drugs that combine precision cancer-targeting agents with toxins or radioisotopes, to create powerful and safe treatments for many forms of cancer with a $15 billion market potential. An in-depth analysis of the dynamic cancer market, cancer treatment, TPCT development, TPCT economic and reimbursement issues, as well as an examination of companies developing these novel drugs are included.
Dr. Philip Cohen, the principal author of the report, will be interviewed in depth on the key industry trends and expected future developments. After the interview, lines will be open for viewers and listeners questions.
The panel discussion will be broadcast live on October 11 at 11 AM Eastern Time and may be accessed through http://www.veomed.com/grandrounds?gnr=871099. The login details are: Username:email@example.com
Questions from the audience will be accepted via https://global.gotomeeting.com/join/681583853.
The details are as follows:
Dial +1 (805) 309-0027
Access Code: 681-583-853
Audio PIN: Shown after joining the meeting
Meeting ID: 681-583-853
Key Highlights of the Report
About the authors
The 100+ page report was compiled over several months by a team with extensive and varied experience in healthcare. Key members are:
About our services
Parthenon Associates provides consulting and strategic advisory services to companies in the Life Sciences, Biotechnology, and Development-Stage Technology industries. Parthenon's Corporate Services include advising companies on product development acquisitions and product licensing, investor relations, and capital markets issues.
Robert LeBoyer, Principal. T: (914) 594-4931. firstname.lastname@example.org.
SOURCE Parthenon Associates, LLC